erlotinib hydrochloride has been researched along with betulinic acid in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (betulinic acid) | Trials (betulinic acid) | Recent Studies (post-2010) (betulinic acid) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 1,025 | 1 | 676 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | betulinic acid (IC50) |
|---|---|---|---|
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | 11.2 | |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | 11.2 | |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | 11.2 | |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2 | |
| DNA polymerase beta | Rattus norvegicus (Norway rat) | 6.5 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 1.5 | |
| 5'-nucleotidase | Homo sapiens (human) | 7.28 | |
| Non-structural protein 1 | Dengue virus | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HY; Chen, HC; Chien, PJ; Hung, WH; Ko, JL; Lin, CH; Wang, BY | 1 |
1 other study(ies) available for erlotinib hydrochloride and betulinic acid
| Article | Year |
|---|---|
Effects and mechanisms of betulinic acid on improving EGFR TKI-resistance of lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Pentacyclic Triterpenes; Protein Kinase Inhibitors; Signal Transduction; Triterpenes | 2018 |